2023 annual financial data
Abeona Therapeutics 2023 Net margin
Direct answer
Net margin was -1,548.23%.
Operating income was -47,135,000 USD and net income was -54,188,000 USD.
Operating cash flow was -37,009,000 USD.
Get free Abeona Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,500,000 USD
- Operating income
- -47,135,000 USD
- Net income
- -54,188,000 USD
- Operating cash flow
- -37,009,000 USD